Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $165000.0.

  • Lisata Therapeutics' Non Operating Income fell 5935.96% to $165000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $874000.0, marking a year-over-year decrease of 5511.04%. This contributed to the annual value of $1.6 million for FY2024, which is 3593.38% down from last year.
  • According to the latest figures from Q3 2025, Lisata Therapeutics' Non Operating Income is $165000.0, which was down 5935.96% from $209000.0 recorded in Q2 2025.
  • Lisata Therapeutics' 5-year Non Operating Income high stood at $703000.0 for Q3 2023, and its period low was $161000.0 during Q1 2025.
  • Over the past 3 years, Lisata Therapeutics' median Non Operating Income value was $406000.0 (recorded in 2024), while the average stood at $427181.8.
  • In the last 5 years, Lisata Therapeutics' Non Operating Income crashed by 752.9% in 2024 and then crashed by 5995.02% in 2025.
  • Over the past 3 years, Lisata Therapeutics' Non Operating Income (Quarter) stood at $660000.0 in 2023, then crashed by 48.64% to $339000.0 in 2024, then crashed by 51.33% to $165000.0 in 2025.
  • Its Non Operating Income was $165000.0 in Q3 2025, compared to $209000.0 in Q2 2025 and $161000.0 in Q1 2025.